The treatment of neonatal isoimmune thrombocytopenia with intravenous immunoglobin (IgG i.v.)
β Scribed by Sidiropoulos, D. ;Straume, B.
- Publisher
- Springer-Verlag
- Year
- 1984
- Weight
- 207 KB
- Volume
- 48
- Category
- Article
- ISSN
- 1432-0584
No coin nor oath required. For personal study only.
β¦ Synopsis
We present a report of the use of IgG i.v. to treat clinically manifest neonatal immune thrombocytopenia. The IgG i.v. was administered at a daily dosage of 0.4 g/kg body weight for 5 days. Treatment was started when the child was 3 days old and had a platelet count of 2 X 10(9)/l. Four days later the platelet count had risen to 200 X 10(9)/l. The diagnosis of immune thrombocytopenia was confirmed by platelet typing of the mother's and child's platelets and identification of anti-platelet antibodies in maternal serum.
π SIMILAR VOLUMES
Infection with the human immunodeficiency virus (HIV) frequently is complicated with thrombocytopenia (HIV-Thr) during all stages of the infection. The treatments for autoimmune thrombocytopenic purpura (ITP) are used in HIV-Thr; however, their effects upon the immune status of patients with acquire